Telus Walk to Cure Diabetes on Sunday
The Juvenile Diabetes Research Foundation and Telus believe in a world where type 1 diabetes (T1D) does not exist. With the support of thousands of Canadians, they’re working together to achieve this monumental milestone, one step at a time.
Every step taken by every participant helps the TELUS Walk to Cure Diabetes achieve major milestones in both awareness and fundraising for T1D research. Landmark advances in T1D science — spanning advanced technology like the artificial pancreas, cutting-edge immune therapies, and the prevention of diabetes complications — are made possible by the personal milestones people achieve when they participate by walking, by fundraising, or by encouraging people to donate.
“T1D is an extraordinarily challenging disease. The number of children living with this continues to increase by three to five per cent annually,” said Andrew McKee, president and CEO of JDRF. “Striking suddenly, it’s a devastating diagnosis for the whole family, which is why the Telus Walk to Cure Diabetes is so significant. Every dollar raised moves us even closer to achieve our mission of finding a cure for T1D and its complications.”
This year, on Sunday, June 10, at Mission Creek Regional Park, 8:30 a.m. to 1 p.m., join the more than 70 communities across the country who will be walking towards curing, better treating and preventing T1D by helping to achieve this year’s biggest fundraising milestone ever— $7.9 million.
“This year we are celebrating the milestones in diabetes research because we can see firsthand how far we have come in treating this disease,” said McKee. “Every day we see how awareness and fundraising help drive research outcomes, moving us closer to the ultimate milestone of finding a cure.”
Now in its 18th year, the Telus Walk to Cure Diabetes will take place in 70 locations across the country to raise money for research. People can sign up individually, in teams of family and friends, or as organizational teams.
“What drives our commitment to supporting Type 1 diabetes research is the very real possibility of finding a cure,” said Joe Natale, Telus chief commercial officer and national chair of the 2012 TELUS Walk to Cure Diabetes. “A world without Type 1 diabetes isn’t here – yet. But we can get there if we work together. Please join the TELUS family in communities across Canada this summer as we raise awareness and funds. Every step we take as sponsors, team captains and individual walkers brings us closer to finding a cure.”
To join the TELUS Walk to Cure Diabetes, visit www.jdrf.ca/walk.
T1D, the most severe form of diabetes, is a non-preventable autoimmune disease that strikes children and adults suddenly and lasts a lifetime. More than 300,000 Canadians and their families suffer from this disease and are faced with its devastating complications.
Unlike type 2 diabetes, T1D cannot be prevented by diet, exercise or medication. Living with the disease demands constant blood testing and regulating. Someone living with T1D requires approximately 1,500 needles and 2,200 finger-pokes each year to test their blood sugar.
Insulin is not a cure for diabetes, nor does it prevent its eventual complications.
How You Can Help
• Participate by walking in your community, register at www.jdrf.ca/walk.
• Pledge to fundraise by asking friends, family or co-workers to support you in achieving your Telus Walk milestones, and because every dollar counts, raise a suggested minimum fundraising amount of $100 and show your spirit on event day.
• Donate to someone else’s efforts – and everyone can make a general donation to support the 2012 Telus Walk to Cure Diabetes.
JDRF is the leading global organization focused on T1D research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research.
The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970 (1974 in Canada), JDRF has awarded more than $1.6 billion to diabetes research globally. The JDRF Canadian Clinical Trial Network, or JDRF CCTN, is a stellar example of the difference fundraising makes to T1D research in Canada:
• The federal government committed $20 million and JDRF provided an additional $13.9 million;
• The $33.9 million investment will help accelerate the testing of new technologies and treatments for Canadians and individuals around the world living with T1D and its complications;
• As of March 31, 2012, the CCTN had successfully delivered by launching nine trials;
• Since 2008, TELUS has raised more than $5.7 million via the TELUS Walk to Cure Diabetes, corporate sponsorship, matching programs and cause marketing initiatives; and
• More than 80 per cent of JDRF's expenditures directly support research and research-related education.